The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicity

The anthracycline doxorubicin (Dox) is widely used in oncology, but it may cause a cardiomyopathy with bleak prognosis that cannot be effectively prevented. The secretome of human amniotic fluid-derived stem cells (hAFS) has previously been demonstrated to significantly reduce ischemic cardiac damag...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazzarini, Edoardo, Balbi, Carolina, Altieri, Paola, Pfeffer, Ulrich, Gambini, Elisa, Canepa, Marco, Varesio, Luigi, Bosco, Maria Carla, Coviello, Domenico, Pompilio, Giulio, Brunelli, Claudio, Cancedda, Ranieri, Ameri, Pietro, Bollini, Sveva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956770/
https://www.ncbi.nlm.nih.gov/pubmed/27444332
http://dx.doi.org/10.1038/srep29994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956770/
https://www.ncbi.nlm.nih.gov/pubmed/27444332
http://dx.doi.org/10.1038/srep29994

Ejemplares similares